Therefore, the decreased expression of HOGA1 might be a diagnostic indicator of PDAC, and inhibiting LARP7, which collaborated with HOGA1, would provide another feasible strategy for suppressing pancreatic cancer development in clinic. The gene discussed is LARP7; the disease is pancreatic neoplasm.